GlassScriptPhysician profile
Beth A Hoekstra
NPI 1922272772
$3,920.93
in general payments reported to CMS, 2019-2025
36 companies · $947 in 2025
The $947 reported for 2025 was more than what 82% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $715 · 2022: $422 · 2023: $936 · 2024: $900 · 2025: $947.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,698 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,698.41 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $797.58 | 2021-2025 | |
| Novo Nordisk INC | $725.21 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Pfizer INC. | $325.77 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $317.66 | 2021-2025 | Airsupra, Farxiga |
| Astellas Pharma US INC | $209.66 | 2023-2025 | Veozah |
| Amgen INC. | $203.42 | 2021-2025 | Otezla, Repatha, Repatha |
| Glaxosmithkline, LLC. | $188.89 | 2023-2025 | Shingrix, Arexvy |
| Lilly USA, LLC | $122.28 | 2021-2024 | Mounjaro, Zepbound |
| Bausch Health US, LLC | $101.38 | 2021-2023 | Aplenzin |
| Biohaven Pharmaceutical Holding Company LTD. | $84.11 | 2022 | |
| Merck Sharp & Dohme LLC | $80.42 | 2021-2023 | Pneumovax 23, Vaxneuvance, Vaxelis |
| Boston Scientific Corporation | $74.30 | 2023-2025 | Wavewriter Alpha Prime 16, General - Therapies |
| Esperion Therapeutics, INC. | $73.09 | 2021-2023 | Nexletol |
| Edwards Lifesciences Corporation | $59.82 | 2023-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Bayer Healthcare Pharmaceuticals INC. | $49.61 | 2022-2023 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aimmune Therapeutics, INC. | $43.43 | 2025 | Zenpep |
| Idorsia Pharmaceuticals US INC | $42.63 | 2023-2024 | Quviviq |
| Biohaven Pharmaceuticals, INC. | $38.88 | 2021 | |
| Exeltis, USA INC. | $38.76 | 2023-2025 | Slynd |
| Nevro Corp. | $38.35 | 2022-2023 | Senza |
| Eisai INC. | $31.47 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $26.62 | 2021 | |
| Hologic Sales and Service, LLC | $23.70 | 2025 | Aptima, Thinprep 2000 Processor |
| Optinose US, INC. | $23.12 | 2021 | |
| Inspire Medical Systems, INC. | $22.39 | 2023 | Inspire |
| Axsome Therapeutics, INC. | $19.74 | 2025 | Auvelity |
| Organon LLC | $18.95 | 2025 | Nexplanon |
| Cranial Technologies, INC | $17.67 | 2025 | Doc Band |
| Paratek Pharmaceuticals, INC. | $17.44 | 2023 | Nuzyra |
| Amarin Pharma, INC. | $17.24 | 2021 | |
| Azurity Pharmaceuticals, INC. | $15.83 | 2025 | Edarbi |
| Amneal Pharmaceuticals LLC | $15.13 | 2023 | Unithroid |
| Genentech USA, INC. | $14.74 | 2021 | |
| Janssen Pharmaceuticals, INC | $14.58 | 2021 | |
| Medtronic, INC. | $13.87 | 2025 | Inceptiv |
| Exact Sciences Corporation | $13.19 | 2023 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Beth Hoekstra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.